Bechtel S Pharmacy Inc Durable Medical Equipment & Medical Supplies Location: 302 Main St, Slatington, Pennsylvania 18080 Phone: (610) 767-4121 |
News Archive
When a young athlete dies unexpectedly on the basketball court or the football field, it's both shocking and tragic. Now Stanford University School of Medicine researchers have, for the first time, identified the molecular basis for a condition called hypertrophic cardiomyopathy that is the most common cause for this type of sudden cardiac death.
The overuse of opioids has become a national crisis, particularly among adolescents who are considered "at risk" for opioid abuse once the medication has been prescribed to them for pain management.
Theravance, Inc. (NASDAQ: THRX) and Astellas Pharma US, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved VIBATIV™ (telavancin) for the treatment of adult patients with complicated skin and skin structure infections (cSSSI) caused by susceptible Gram-positive bacteria, including Staphylococcus aureus, both methicillin-resistant (MRSA) and methicillin-susceptible (MSSA) strains.
Cyndia Charfi, a Ph. D student in biology at Universit- du Qu-bec - Montr-al (UQAM), supported by her thesis supervisors, Professor -ric Rassart, and Adjunct Professor Elsy Edouard, UQAM, Department of Biological Sciences and BIOMED Research Centre, made a major breakthrough in research on B-cell acute lymphocytic leukemia, a disease that occurs most commonly in children.
Samsung and Biogen Idec today announced that they have entered into an agreement to invest $300 million to establish a joint venture to develop, manufacture and market biosimilars. Samsung will take a leading role in the joint venture, with Biogen Idec contributing its expertise in protein engineering and biologics manufacturing.
› Verified 9 days ago